| Year |
Citation |
Score |
| 2023 |
van Andel DM, Sprengers JJ, Königs M, de Jonge MV, Bruining H. Effects of Bumetanide on Neurocognitive Functioning in Children with Autism Spectrum Disorder: Secondary Analysis of a Randomized Placebo-Controlled Trial. Journal of Autism and Developmental Disorders. PMID 36626004 DOI: 10.1007/s10803-022-05841-3 |
0.326 |
|
| 2022 |
Diachenko M, Houtman SJ, Juarez-Martinez EL, Ramautar JR, Weiler R, Mansvelder HD, Bruining H, Bloem P, Linkenkaer-Hansen K. Improved Manual Annotation of EEG Signals through Convolutional Neural Network Guidance. Eneuro. 9. PMID 36104277 DOI: 10.1523/ENEURO.0160-22.2022 |
0.691 |
|
| 2022 |
Juarez-Martinez EL, van Andel DM, Sprengers JJ, Avramiea AE, Oranje B, Scheepers FE, Jansen FE, Mansvelder HD, Linkenkaer-Hansen K, Bruining H. Bumetanide Effects on Resting-State EEG in Tuberous Sclerosis Complex in Relation to Clinical Outcome: An Open-Label Study. Frontiers in Neuroscience. 16: 879451. PMID 35645706 DOI: 10.3389/fnins.2022.879451 |
0.758 |
|
| 2022 |
van Andel DM, Sprengers JJ, Keijzer-Veen MG, Schulp AJA, Lillien MR, Scheepers FE, Bruining H. Bumetanide for Irritability in Children With Sensory Processing Problems Across Neurodevelopmental Disorders: A Pilot Randomized Controlled Trial. Frontiers in Psychiatry. 13: 780281. PMID 35211042 DOI: 10.3389/fpsyt.2022.780281 |
0.356 |
|
| 2022 |
Geertjens L, van Voorst TW, Bouman A, van Boven MA, Kleefstra T, Verhage M, Linkenkaer-Hansen K, Nadif Kasri N, Cornelisse LN, Bruining H. Following Excitation/Inhibition Ratio Homeostasis from Synapse to EEG in Monogenetic Neurodevelopmental Disorders. Genes. 13. PMID 35205434 DOI: 10.3390/genes13020390 |
0.677 |
|
| 2021 |
Houtman SJ, Lammertse HCA, van Berkel AA, Balagura G, Gardella E, Ramautar JR, Reale C, Møller RS, Zara F, Striano P, Misra-Isrie M, van Haelst MM, Engelen M, van Zuijen TL, Mansvelder HD, ... ... Bruining H, et al. Syndrome Is Characterized by Inhibition-Dominated Dynamics of Resting-State EEG. Frontiers in Physiology. 12: 775172. PMID 35002760 DOI: 10.3389/fphys.2021.775172 |
0.728 |
|
| 2021 |
Juarez-Martinez EL, Sprengers JJ, Cristian G, Oranje B, van Andel DM, Avramiea AE, Simpraga S, Houtman SJ, Hardstone R, Gerver C, Jan van der Wilt G, Mansvelder HD, Eijkemans MJC, Linkenkaer-Hansen K, Bruining H. Prediction of behavioral improvement through resting-state EEG and clinical severity in a randomized controlled trial testing bumetanide in autism spectrum disorder. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 34506972 DOI: 10.1016/j.bpsc.2021.08.009 |
0.72 |
|
| 2020 |
Bruining H, Hardstone R, Juarez-Martinez EL, Sprengers J, Avramiea AE, Simpraga S, Houtman SJ, Poil SS, Dallares E, Palva S, Oranje B, Matias Palva J, Mansvelder HD, Linkenkaer-Hansen K. Measurement of excitation-inhibition ratio in autism spectrum disorder using critical brain dynamics. Scientific Reports. 10: 9195. PMID 32513931 DOI: 10.1038/S41598-020-65500-4 |
0.737 |
|
| 2019 |
Juarez Martinez EL, Bruining H, Sprengers J, Simpraga S, Houtman S, Poil S, Mansvelder HD, Jansen F, Oranje B, Hardstone R, Linkenkaer-Hansen K. O-20 Epileptiform and non-epileptiform EEG abnormalities in Autism Spectrum Disorder relate to opposite excitation-inhibition balance disturbances Clinical Neurophysiology. 130: e27-e28. DOI: 10.1016/J.Clinph.2019.04.336 |
0.739 |
|
| 2019 |
Marije van Andel D, Sprengers J, Juarez-Martinez E, Simpraga S, Oranje B, Linkenkaer-Hansen K, de Jonge M, Bruining H. 222. Cognitive Outcomes of the Bumetanide in Autism Medication and Biomarker (BAMBI) Trial Biological Psychiatry. 85: S92. DOI: 10.1016/J.Biopsych.2019.03.236 |
0.573 |
|
| 2019 |
Sprengers J, Oranje B, Marije van Andel D, Juarez-Martinez E, Simpraga S, Linkenkaer-Hansen K, Bruining H. 221. Behavioural and Neurophysiological Outcomes of the Bumetanide in Autism Medication and Biomarker (BAMBI) Trial Biological Psychiatry. 85: S91-S92. DOI: 10.1016/J.Biopsych.2019.03.235 |
0.591 |
|
| 2019 |
Bruining H, Juarez-Martinez E, Sprengers J, Marije van Andel D, Simpraga S, Poil S, Dellares E, Mansvelder H, Oranje B, Hardstone R, Linkenkaer-Hansen K. 220. Non-Invasive Estimation of Excitation-Inhibition Balance Facilitates Physiological Dissection of Autism Spectrum Disorder Biological Psychiatry. 85: S91. DOI: 10.1016/J.Biopsych.2019.03.234 |
0.714 |
|
| 2017 |
Vlaskamp C, Poil SS, Jansen F, Linkenkaer-Hansen K, Durston S, Oranje B, Bruining H. Bumetanide As a Candidate Treatment for Behavioral Problems in Tuberous Sclerosis Complex. Frontiers in Neurology. 8: 469. PMID 28943860 DOI: 10.3389/Fneur.2017.00469 |
0.573 |
|
| 2017 |
Srengers J, Martinez EJ, Simpraga S, Jansen F, Vlaskamp C, Oranje B, Poil S, Linkenkaer-Hansen K, Bruining H. O132 An EEG-based decision-support system for diagnosis and prognosis of autism spectrum disorder Clinical Neurophysiology. 128: e221. DOI: 10.1016/J.Clinph.2017.07.143 |
0.732 |
|
| 2015 |
van Campen JS, Jansen FE, Kleinrensink NJ, Joëls M, Braun KP, Bruining H. Sensory modulation disorders in childhood epilepsy. Journal of Neurodevelopmental Disorders. 7: 34. PMID 26504494 DOI: 10.1186/s11689-015-9130-9 |
0.351 |
|
| 2015 |
Bruining H, Passtoors L, Goriounova N, Jansen F, Hakvoort B, de Jonge M, Poil SS. Paradoxical Benzodiazepine Response: A Rationale for Bumetanide in Neurodevelopmental Disorders? Pediatrics. 136: e539-43. PMID 26216321 DOI: 10.1542/peds.2014-4133 |
0.311 |
|
| 2015 |
van Diessen E, Senders J, Jansen FE, Boersma M, Bruining H. Increased power of resting-state gamma oscillations in autism spectrum disorder detected by routine electroencephalography. European Archives of Psychiatry and Clinical Neuroscience. 265: 537-40. PMID 25182536 DOI: 10.1007/s00406-014-0527-3 |
0.396 |
|
| 2010 |
Bruining H, de Sonneville L, Swaab H, de Jonge M, Kas M, van Engeland H, Vorstman J. Dissecting the clinical heterogeneity of autism spectrum disorders through defined genotypes. Plos One. 5: e10887. PMID 20526357 DOI: 10.1371/journal.pone.0010887 |
0.321 |
|
| Show low-probability matches. |